Operates retail food stores under corporate and franchise ownership. Operates associate-owned drug stores. Now — the numbers.
This is an established company with proven profits.
No real growth (5% a year).
The gap is $17.4B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 26.9× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Trading Liquidity: The shares change hands too rarely for smooth trading.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
It pays out $0.42 per share each year — regular cash for whoever holds the stock.
Getting in and out without moving the price could prove difficult. Council score: 2/10.
The price action doesn’t yet back an upward turn. Council score: 3/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
Against everything we grade, LBLCF lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: LBLCF does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.